INTRODUCTION
Diabetes mellitus is a metabolic disorder of multiple etiology. It is characterized by chronic hyperglycemia with disturbance of carbohydrate, fat and protein metabolism resulting from the defect in insulin secretion, insulin action or both.
[1] The majority of diabetes cases are divided into two broad etiopathogenic categories. The first category (type 1 diabetes) occurs due to the absolute deficiency of insulin. Only 5-10 % diabetics are affected by this type of diabetes. The other more prevalent category (type 2 diabetes) occurs mostly due to combination of insulin resistance and inadequate compensatory insulin secretary response. [2] One therapeutic approach to treat diabetes is to decrease post -prandial hyperglycemia. This is done by retarding and reducing the digestion and absorption of glucose through the inhibition of carbohydratehydrolyzing enzymes such as α-glucosidase and α -amylase in the digestive tract. Inhibition of these enzymes delays the digestion of the carbohydrates, causing a reduction in the rate of glucose absorption. [3] Stabilization of blood glucose prevents hyperglycemia and the complications associated with the diabetes. [4] Long-term secondary complications are the main cause of morbidity and mortality in diabetic patients. [5] The major microvascular complications of diabetes include nephropathy, neuropathy and retinopathy. Cataract is another vascular complication. [6] Several metabolic factors contribute to the dysfunction observed in diabetic vasculopathy. [7] These include increased glucose flux through the polyol pathway, increased production of reactive oxygen species by the mitochondrial respiratory chain, nonenzymatic glycations, protein kinase-C activation and increased flux through the hexosamine pathway. [5] The increase in the level of ROS in diabetes may be due to their increased production and/ or decreased destruction by enzymic catalase (CAT), glutathione peroxidase (GSH-Px), and superoxide dismutase (SOD) antioxidants. The level of these antioxidant enzymes critically influences the susceptibility of various tissues to oxidative stress and is associated with the development of complications in diabetes. [6] .
Aldose reductase is the first and rate-limiting enzyme in the polyol pathway. [8] Another long term complication of the diabetes is hypertension (high blood pressure). Angiotensin converting enzyme is an important enzyme involved in vascular tension. [9] Along with Oxidative stress, this also plays a central role in the onset of diabetes mellitus.
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KEY WORDS: diabetes, flavonoids, α-glucosidase, α-amylase, DDP4, ACE inhibitor reduction in the rate of glucose absorption, consequently blunting increased post -prandial plasma glucose levels. [3] Because of their purported ability to prevent starch breakdown and absorption, α-amylase inhibitors have been used for weight loss in humans. [13] Acarbose and viglibose are currently used as α-amylase and α-glucosidase inhibitors, but also induce side effects such as abdotension, bloating, flatulence and diarrhea. [14] It has been suggested that such adverse effects might be caused by the excessive inhibition pancreatic α-amylase resulting in the abnormal bacterial fermentation of undigested carbohydrates in the colon. [15] Therefore, natural α-amylase inhibitors from the dietary plants can be used as effective therapy for post prandial hyperglycemia with minimal side effects. [16] Plants with inhibitory activity against α-glucosidase enzyme have been summarized in table 1. and animal tissues [10] . The α-amylase mainly synthesizes in plants, near the starch deposit sites and also presents along the digestive tract of phytophagous animals range from insects to mammals. [11] Pancreatic α-amylase is the key enzyme in the digestive system. It catalyses the initial step in the hydrolysis of starch to a mixture of small oligosaccharide consisting of maltose, maltotriose and a number of α-(1-6) and α-(1-4) oligoglucans. These are then acted on by α-glucosidases and further degraded to glucose which on absorption enters to bloodstream. Degradation of dietary starch proceeds rapidly and leads to elevated post-prandial hyperglycemia. [12] Plants with inhibitory activity against α-glucosidase enzyme have been summarized in is considered a useful therapeutic approach in the treatment of high blood pressure in both diabetic and non-diabetic patients. [21] Some plants which show inhibitory activity against this enzyme are discussed in table 5.
Another novel approach for treatment of type-2 diabetes is based on the gut hormone glucagon-like peptide-1 (GLP-1) which is anti-diabetic due to its combined action of stimulating insulin secretion, increasing beta-cell mass, inhibiting glucagon secretion, reducing the rate of gastric emptying and inducing satiety. The peptide is rapidly inactivated by dipeptidyl peptidase-IV (DPP-4), resulting in a half-life of active GLP-1 of only approximately 1-2 minutes. Inhibition of DPP-IV increases the levels of endogenous active GLP-1 and prolongs its half-life. Studies on animals have shown genetic deletion of DPP-IV improved glucose tolerance and increased insulin secretion in response to oral glucose. [22] Some plant extracts which have shown inhibitory activity against this enzyme are summarised in table 4.
Oxidative stress plays a central role in the onset of diabetes mellitus as well as in the development of vascular and neurologic complications of the disease.
[23)] The source of oxidative stress is a cascade of reactive oxygen species Aldose reductase is a member of the aldo-keto reductases (AKR) super family. It is the first and rate-limiting enzyme in the polyol pathway and reduces glucose to sorbitol, utilizing NADPH as a cofactor. Sorbitol is then metabolized to fructose by sorbitol dehydrogenase. [17] In diabetes mellitus, the increased availability of glucose in insulin-insensitive tissue such as lens, nerve, and retina leads to increased formation of sorbitol through the polyol pathway. Sorbitol does not readily diffuse across the cell membranes. Intracellular accumulation of sorbitol has been implicated in chronic complications of diabetes such as cataract, neuropathy and retinopathy. Aldose reductase inhibitors prevent the conversion of glucose to sorbitol and may have the capacity to prevent diabetic complications. [18] Quercetin, quercitrin, and myricitrin are potent aldose redutase inhibitors. [19] Some plants show inhibitory activity against this enzyme and are summarised in table 3.
Angiotensin I-converting enzyme (ACE) is an important enzyme involved in maintaining vascular tension. ACE activates a histidyl-leucine dipeptide called angiotensin I, into a potent vasoconstrictor called angiotensin II. [10] Angiotensin II stimulates the synthesis and release of aldosterone, which increases blood pressure by promoting sodium retention in the distal tubules.
[20] Inhibition of ACE (20) Guaijaverin ( influence of diabetes mellitus metabolism of tissues on various organ is well known. Glucose control plays a role in the pro-oxidant/antioxidant balance. [30] Antioxidants, which can scavenge free radicals have an important role in biological systems and may be helpful in the prevention of the cancer, heart diseases, ageing and diabetes mellitus. [31] A list of plant extracts which show inhibitory activity against antioxidant enzymes are summarised in table 6.
Inhibition of α-Amylase by Flavonoids
The inhibitory activity of six groups of flavonoids (1-4) against porcine pancreatic α-amylase was compared and chemical structures of flavonoids responsible for the inhibitory activity were evaluated. [67] In porcine pancreatic α-amylase, luteolin, myricetin and quercitin were potent inhibitors with IC 50 values of 0.36, 0.38 and 0.50 mM respectively. The inhibitory activity increased appreciably with an increase in the number of hydroxyl group on the B ring, while the hydroxyl substitution on the position 3 reduces it. Among the six group of flavonoids, (ROS) leaking from the mitochondria. [24] This process has been associated with the onset of type 1 diabetes via apoptosis of pancreatic beta-cells and the onset of type 2 diabetes via insulin resistance. [25] The underlying mechanisms in the onset of diabetes are complex because hyperglycemia may be both a cause and an effect of increased oxidative stress. [26] Hyperphysiological burden of free radicals causes an imbalance between oxidants and antioxidants in the body. This imbalance leads to oxidative stress that is being suggested as the root cause of ageing and various human diseases including atherosclerosis, stroke, diabetes, cancer and neurodegenerative diseases such as Alzheimer's and Parkinsonism. [27] Alloxan is a chemical used for the induction of diabetes in animals. It has been shown to damage pancreatic β-cell by the liberation of oxygen radicals, with reduction in the antioxidant status. [28] Insulin deficiency promotes β-oxidation of fatty acids , which results in the increased formation of hydrogen peroxide. [29] The harmful 
Terpinoids
A mixture of oleanolic acid (13) and ursolic acid (14) , triterpenoid isolated from Phyllanthus amarus, (Phyllanthaceae) exhibit inhibitory activity against α-amylase with an IC 50 value of 2.01 μg/ml.
[68]
Miscellaneous
The bioactivity assay-guided study of a methanolic extract of the Spondias mombin (Anacardiaceae) lead to the isolation of the active compound 3β-olean -12 -en-3 yl (9z)-hexadec-9-enoate which shows the 57 % inhibitory activity against α-amylase.
[69]
Xanthone Glucoside
Mangiferin (15) (xanthone glucoside) isolated from the ethanolic extract of Mangifera indica (Anacardiaceae) showed appreciable α-amylase inhibitory effects with an IC 50 value of 74.35 ± 1.9 mg/ml. [51] p-cymene, 1,8 -cineole, 1-(S)-α-pinene, are the major components isolated from the essential oil of the Eucalyptus camaldulensis Dehnh (Myrtaceae). These compounds show inhibitory activity against α-amylase with the percentage inhibition 36.50 ± 1.50, 43.23 ± 2.57, 32.22 ± 1.73 respesctively at the conc. of the 0.015, 0.075, 0.075 μl/ ml. [70] 
Anthocyanin
Cyanidine (16) and its glycoside cyanidine-3-glucoside (anthocyanins) are widely distributed in various in isoflavone show maximal and flavanone show minimum inhibitory effect. [67] The flavonoid compounds quercetin, kaempferol, myricetin isolated from the 70% ethanol extract of the guava leaf (further extracted with the n-butanol) show the inhibitory activity against α-amylase with IC 50 values of 4.8mM, 5.3mM, 4.3mM respectively. Further extraction of the 70 % ethanol leaf extract of the leaf with the ethyl acetate also show the potent inhibitory activity against the α-amylase due to presence of these flavonoids with the same value of IC 50 .
[59]
Phenolics
(-)-3-O-galloylepicatechin (5) and (-) -3-O -galloylcatechin (6) isolated from 50 % methanolic extracts of Bergenia ciliata show the α -amylase inhibitory activity with the value of IC 50 739 μM and 401 μM, respectively. [39] Tannins and ellagic acid (7) derivatives isolated from Lagerstroemia speciosa (banaba) (Lythraceae) leaves are potent inhibitors of α-amylase. Valoneaic acid dilactone (8) is the main active constituent isolated from the leaf extracts. It shows potent inhibitory activity against the α-amylase. [48] Phenolic compounds such as gallic acid (9), gentisic acid, caffeic acid (10), ferulic acid (11) etc. isolated from Elusine coracana acidified methanol extracts show the inhibitory activity towards the α-amylase with a IC 50 value of 23.05Μg/ ml.
[46]
Alkaloids
Carbazole alkaloid mahanimbine (12) isolated from pet. ether extracts of the leaves of Murraya koenigii (Rutaceae) showed [71] Cyanidine-3-rutinoside is a colorant found in plants including litchi and capulin. It inhibits pancreatic α-amylase with an value of IC 50 24.4 ± 0.1 μΜ. [72] Some of the common phytochemicals used in the treatment of diabetes are shown in Figure 1 
CONCLUSION
Diabetes mellitus is the one of the major health problem, affecting around 194 millions of the population worldwide, and that number is expected to increase to 300 million by 2025. [101] Most of these will dominated by the type 2 diabetes mellitus. [102] This increasing trend in type 2 diabetes has [103, 104] Therefore apart of these medicines herbal medicine are recommended for treatment of diabetes. [105] One of the therapeutic approach to treat the diabetes is to control the blood glucose level, and this can be done by inhibiting the all enzymes such as alpha amylase, alpha glucosidase, DPP-4, and aldose reductase, etc. Thus, natural become a serious medical concern worldwide, which accounts for 9 % of deaths. One of the therapeutic approach to control the diabetes is to control the hyperglycemia. [3] The modern medicines available for the management of diabetes show various side effects such as hepatotoxicity, abdominal pain etc. and drug resistance to these medicine products are still a good source of all these inhibitors therefore motivating the use of the natural products. Thus, natural products of great structural diversity are still a good source for searching for such inhibitors, thereby motivating to explore biologically active compounds from the highly diverse plants.
